Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Super-boosted Lopinavir/Ritonavir with Rifampin in HIV/TB Patients
NCT01700790Phase 4Terminated
- Sponsor
- University of Miami
- Start
- Feb 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ritonavir in human immunodeficiency virus type 1 infection (HIV-1), Tuberculosis (TB), sponsored by University of Miami. Started Feb 2016; status: terminated.
02
Drugs
ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01700790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01700790.